GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Teduglutide

Company
University Health Network, Toronto
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
3 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

3 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for Teduglutide and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT05561647

    A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)

    Takeda 600 participants Est. completion 2031-12-31 1 site
    Other conditions: Short Bowel Syndrome (SBS)
    View official trial listing →
  • Recruiting NCT NCT07319832

    A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome

    Takeda 12 participants Est. completion 2027-09-30 4 sites
    Other conditions: Short Bowel Syndrome (SBS)
    View official trial listing →
  • Recruiting NCT NCT07400783

    TED_ORG: Study on Short Bowel Syndrome

    Not yet reported Meyer Children's Hospital IRCCS 50 participants Est. completion 2026-10 1 site
    Other conditions: Short Bowel Syndrome (SBS)
    View official trial listing →
  • Completed NCT NCT00072839

    Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease

    Not yet reported Shire 100 participants Est. completion 2005-07-28 26 sites Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00081458

    Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome

    Not yet reported Shire 84 participants Est. completion 2007-07-06 32 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT00172185

    Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

    Not yet reported Shire 65 participants Est. completion 2008-01-24 21 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT00308438

    Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008

    Not yet reported Shire 67 participants Est. completion 2006-06-01 24 sites Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00798967

    Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects

    Not yet reported Shire 86 participants Est. completion 2011-01-25 35 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT00819468

    Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants

    Not yet reported Shire 24 participants Est. completion 2007-08-23 1 site Stand-alone
    Other conditions: Hepatic Impairment
    View official trial listing →
  • Completed NCT NCT00820885

    A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of Teduglutide

    Not yet reported Shire 95 participants Est. completion 2007-04-23 1 site
    Other conditions: Pharmacokinetics and Safety of Elevated Doses
    View official trial listing →
  • Completed NCT NCT00930644

    Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

    Not yet reported Shire 88 participants Est. completion 2013-01-24 23 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT01028768

    Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function

    Not yet reported Nycomed 36 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Renal Impairment
    View official trial listing →
  • Completed NCT NCT01028924

    Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers

    Not yet reported Nycomed 72 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01209351

    Effect of Teduglutide on Gastric Emptying in Healthy Subjects

    Not yet reported Shire 36 participants Est. completion 2010-11-08 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01560403

    A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021

    Not yet reported Shire 14 participants Est. completion 2013-07-23 5 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT01952080

    A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome

    Not yet reported Shire 42 participants Est. completion 2015-01-09 19 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT01990040

    Registry for Participants With Short Bowel Syndrome

    Shire 1806 participants Est. completion 2032-06-30 1 site
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT02099084

    Short Bowel Syndrome and Teduglutide Versus Placebo

    Not yet reported Mayo Clinic 8 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT02340819

    Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)

    Not yet reported Shire 11 participants Est. completion 2018-11-05 5 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT02431325

    A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV

    Not yet reported Massachusetts General Hospital 32 participants Est. completion 2021-01-21 1 site Stand-alone
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT02682381

    Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition

    Not yet reported Shire 59 participants Est. completion 2017-08-18 27 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT02889393

    Teduglutide for Enterocutaneous Fistula (ECF)

    Not yet reported Daniel Dante Yeh 6 participants Est. completion 2021-07-15 1 site Stand-alone
    Other conditions: Postoperative Fistula
    View official trial listing →
  • Completed NCT NCT02949362

    Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

    Not yet reported Shire 29 participants Est. completion 2020-07-14 11 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT02954458

    Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)

    Not yet reported Shire 61 participants Est. completion 2020-11-05 22 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT02980666

    Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support

    Not yet reported Shire 10 participants Est. completion 2020-01-21 5 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT03268811

    A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302

    Not yet reported Shire 9 participants Est. completion 2021-11-02 6 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT03422666

    Plasma Lipoprotein Response to Glucagon-like Peptide-2

    Not yet reported, Not yet reported University Health Network, Toronto 10 participants Est. completion 2021-12-01 1 site Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT03442972

    Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids

    Not yet reported, Not yet reported University Health Network, Toronto 21 participants Est. completion 2021-12-01 2 sites Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT03534661

    L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release

    Not yet reported, Not yet reported University Health Network, Toronto 10 participants Est. completion 2019-03-20 1 site
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT03562130

    Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients

    Not yet reported Assistance Publique - Hôpitaux de Paris 25 participants Est. completion 2020-07-13 1 site Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT03571516

    Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome

    Not yet reported Shire 10 participants Est. completion 2020-09-24 8 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT03596164

    An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004

    Not yet reported Takeda 11 participants Est. completion 2022-01-13 5 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT03663582

    Study of Teduglutide in Japanese Participants With Short Bowel Syndrome

    Not yet reported Shire 7 participants Est. completion 2019-08-06 5 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT03716115

    Therapeutic Approaches to Malnutrition Enteropathy

    Not yet reported Queen Mary University of London 125 participants Est. completion 2021-04-27 3 sites Stand-alone
    Other conditions: Severe Acute Malnutrition
    View official trial listing →
  • Status unknown NCT NCT03860688

    Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins

    Not yet reported, Not yet reported University Health Network, Toronto 15 participants Est. completion 2022-05 1 site Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Withdrawn NCT NCT03953170

    Pilot Study to Investigate the Effect of Teduglutide on Temporary Ileostomy Function and Complications

    Not yet reported Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) Est. completion 2022-12-29 1 site
    Other conditions: Ileostomy - Stoma
    View official trial listing →
  • Completed NCT NCT04290429

    Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients

    Not yet reported University of Freiburg 6 participants Est. completion 2019-12-06 1 site Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Status unknown NCT NCT04344717

    Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition

    Not yet reported Universitaire Ziekenhuizen KU Leuven 84 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Short Bowel Syndrome, Anticoagulation
    View official trial listing →
  • Completed NCT NCT04465396

    A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants

    Not yet reported Shire 64 participants Est. completion 2021-08-20 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT04733066

    Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis

    Charite University, Berlin, Germany 40 participants Est. completion 2022-09 1 site
    Other conditions: Short Bowel Syndrome, Intestinal Failure
    View official trial listing →
  • Completed NCT NCT04832087

    Pediatric Teduglutide Registry

    Boston Children's Hospital 142 participants Est. completion 2023-08-31 1 site
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT04857801

    Teduglutide in Short Bowel Syndrome Patients

    Medical University of Vienna 17 participants Est. completion 2020-06-01
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT04877431

    A Study of Teduglutide (Revestive®) in Children, Teenagers and Adults With Short Bowel Disease

    Takeda 45 participants Est. completion 2023-06-05 1 site
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT04883606

    A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome

    Takeda 65 participants Est. completion 2023-07-24 1 site
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT04916665

    Bridging Intestinal Failure With Teduglutide - a Case Report

    Medical University of Vienna 1 participants Est. completion 2019-12-31 1 site
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT05023382

    A Study of Teduglutide in Japanese People With Short Bowel Syndrome

    Takeda 250 participants Est. completion 2026-07-31 1 site
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT05027308

    A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older

    Not yet reported Takeda 3 participants Est. completion 2023-09-27 6 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT05371028

    A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada

    Takeda 52 participants Est. completion 2025-02-19 1 site
    Other conditions: Short Bowel Syndrome (SBS)
    View official trial listing →
  • Active, not recruiting NCT NCT06973304

    A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome

    Not yet reported Takeda 13 participants Est. completion 2027-07-28 4 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07537686

    Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunction (EED)

    Not yet reported International Centre for Diarrhoeal Disease Research, Bangladesh 55 participants Est. completion 2027-12-30 Stand-alone
    Other conditions: Environmental Enteric Dysfunction
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.